Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-06-12 00:00:00 ET · period of report 2023-06-08 · accession 0001209191-23-036395 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-08 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $20.00 | -100 | 48.1K | -0.2% | -$2,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-08 | S | D | 100 | $20.00 | 48,086 | D | — | — |